Ethosome-Derived Invasomes as a Potential Transdermal Delivery System for Vardenafil Hydrochloride: Development, Optimization and Application of Physiologically Based Pharmacokinetic Modeling in Adults and Geriatrics

被引:43
作者
Ammar, Hussein O. [1 ]
Tadros, Mina Ibrahim [2 ]
Salama, Nahla M. [1 ]
Ghoneim, Amira Mohsen [1 ]
机构
[1] Future Univ Egypt FUE, Fac Pharmaceut Sci & Pharmaceut Ind, Dept Pharmaceut & Pharmaceut Technol, New Cairo, Egypt
[2] Cairo Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo 11562, Egypt
关键词
vardenafil hydrochloride; ethosomes; invasomes; transdermal; physiologically based pharmacokinetic modeling; PULMONARY ARTERIAL-HYPERTENSION; IN-VITRO; PROPRANOLOL HYDROCHLORIDE; PERCUTANEOUS-ABSORPTION; ERECTILE DYSFUNCTION; SKIN PENETRATION; IONIC-STRENGTH; DOUBLE-BLIND; EX-VIVO; FORMULATION;
D O I
10.2147/IJN.S261764
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Aim: The aim of the current work was to develop vardenafil hydrochloride (VRD)-loaded ethosome-derived invasomes as a possible transdermal system which could be used for patients suffering from pulmonary arterial hypertension. Methods: VRD-loaded ethosomes were developed at three concentrations of phosphatidylcholine (5, 10 and 15 mg/mL) and three percentages of ethanol (20%, 30% and 40%, v/v). The best achieved VRD-loaded ethosomes (ETH9) were optimized to invasomes via incorporation of terpenes (limonene, cineole and a 1:1 mixture) at three concentrations (0.5%, 1% and 2%, v/v). All systems were evaluated for vesicle size, zeta potential, drug entrapment efficiency (EE%), cumulative drug permeated percentages after 0.5hrs (Q(0.5h)) and 12hrs (Q(12h)) and steady-state flux (J(ss)). The optimized system (ETH9-INV8) was further characterized for morphology, histopathology and confocal laser scanning microscopy (CLSM). Physiologically based pharmacokinetic (PBPK) modeling was employed to estimate VRD pharmacokinetic parameters from the optimized transdermal system and an oral aqueous drug dispersion, in adults and geriatrics. Results: The optimized invasomal system (ETH9-INV8) was characterized with spherical vesicles (159.9 nm) possessing negative zeta potential (-20.3 mV), promising EE% (81.3%), low Q(0.5h) (25.4%), high Q(12h) (85.3%) and the largest steady-state flux (6.4 mu g.cm(-2)h(-1)). Following a leave-on period of 12hrs in rats, it showed minor histopathologic changes. CLSM studies proved its ability to deeply permeate rat skin. Lower C-max values, delayed T-max estimates and greater AUC(0-24h) folds in adults and geriatrics (approximate to 2.18 and 1.69, respectively) were estimated following the transdermal application of ETH9-INV8 system. Conclusion: ETH9-INV8 is a promising transdermal system for VRD.
引用
收藏
页码:5671 / 5685
页数:15
相关论文
共 69 条
[1]   Laminated sponges as challenging solid hydrophilic matrices for the buccal delivery of carvedilol microemulsion systems: Development and proof of concept via mucoadhesion and pharmacokinetic assessments in healthy human volunteers [J].
Abd-Elbary, Ahmed ;
Makky, Amna M. A. ;
Tadros, Mina Ibrahim ;
Alaa-Eldin, Ahmed Adel .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 82 :31-44
[2]   Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: Application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study [J].
Abdelbary, Aly A. ;
AbouGhaly, Mohamed H. H. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 485 (1-2) :235-243
[3]   Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials [J].
Abdulbaqi, Ibrahim M. ;
Darwis, Yusrida ;
Khan, Nurzalina Abdul Karim ;
Abou Assi, Reem ;
Khan, Arshad A. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2016, 11 :2279-2304
[4]   Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation [J].
Albash, Rofida ;
Abdelbary, Aly A. ;
Refai, Hanan ;
El-Nabarawi, Mohamed A. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 :1953-1968
[5]   Therapeutic Strategies for Erectile Dysfunction With Emphasis on Recent Approaches in Nanomedicine [J].
Ammar, Hussein O. ;
Tadros, Mina I. ;
Salama, Nahla M. ;
Ghoneim, Amira M. .
IEEE TRANSACTIONS ON NANOBIOSCIENCE, 2020, 19 (01) :11-24
[6]   High frequency ultrasound mediated transdermal delivery of ondansetron hydrochloride employing bilosomal gel systems: ex-vivo and in-vivo characterization studies [J].
Ammar, Hussein Osman ;
Mohamed, Magdy Ibrahim ;
Tadros, Mina Ibrahim ;
Fouly, Aya Adel .
JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2020, 50 (06) :613-624
[7]   Vesicular carriers containing phenylethyl resorcinol for topical delivery system; liposomes, transfersomes and invasomes [J].
Amnuaikit, Thanaporn ;
Limsuwan, Tunyaluk ;
Khongkow, Pasarat ;
Boonme, Prapaporn .
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 13 (05) :472-484
[8]   Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension [J].
Archer, SL ;
Djaballah, K ;
Humbert, M ;
Weir, EK ;
Fartoukh, M ;
DalL'Ava-Santucci, J ;
Mercier, JC ;
Simonneau, G ;
Dinh-Xuan, AT .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (04) :1061-1067
[9]  
Ashour Abdelkader E, 2014, Profiles Drug Subst Excip Relat Methodol, V39, P515, DOI 10.1016/B978-0-12-800173-8.00009-X
[10]   Invasome: A Novel Nanocarrier for Transdermal Drug Delivery [J].
Babaie, Soraya ;
Del Bakhshayesh, Azizeh Rahmani ;
Ha, Ji Won ;
Hamishehkar, Hamed ;
Kim, Ki Hyun .
NANOMATERIALS, 2020, 10 (02)